SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 93 filers reported holding SAGE THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $223,000 | -99.6% | 7,395 | -99.5% | 0.02% | -98.1% |
| Q1 2016 | $50,012,000 | -20.2% | 1,559,922 | +45.1% | 0.85% | -9.7% |
| Q4 2015 | $62,690,000 | +64.1% | 1,075,309 | +19.1% | 0.94% | +80.5% |
| Q3 2015 | $38,213,000 | -20.3% | 902,948 | +37.5% | 0.52% | -23.2% |
| Q2 2015 | $47,955,000 | +3718.1% | 656,921 | +2527.7% | 0.68% | +3478.9% |
| Q1 2015 | $1,256,000 | – | 25,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |